Literature DB >> 28711072

Chronic Kidney Disease and Pregnancy.

Michelle A Hladunewich1.   

Abstract

Women with chronic kidney disease (CKD) are at risk for adverse pregnancy-associated outcomes, including progression of their underlying renal dysfunction, a flare of their kidney disease, and adverse pregnancy complications such as preeclampsia and preterm delivery. Earlier-stage CKD, as a rule, is a safer time to have a pregnancy, but even women with end-stage kidney disease have attempted pregnancy in recent years. As such, nephrologists need to be comfortable with pregnancy preparation and management at all stages of CKD. In this article, we review the renal physiologic response to pregnancy and the literature with respect to both expected maternal and fetal outcomes among young women at various stages of CKD, including those who attempt to conceive while on dialysis. The general management of young women with CKD and associated complications, including hypertension and proteinuria are discussed. Finally, the emotional impact these pregnancies may have on young women with a chronic disease and the potential benefits of care in a multidisciplinary environment are highlighted.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pregnancy; chronic kidney disease (CKD); end-stage kidney disease (ESKD); glomerular physiology

Mesh:

Year:  2017        PMID: 28711072     DOI: 10.1016/j.semnephrol.2017.05.005

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  7 in total

1.  Chronic kidney disease in pregnant mothers affects maternal and fetal disposition of mercury.

Authors:  Renee F Moss; Hannah S George; Sanya Nijhara; Sarah E Orr; Lucy Joshee; Jennifer L Barkin; Christy C Bridges
Journal:  Reprod Toxicol       Date:  2020-02-19       Impact factor: 3.143

2.  Maternal Tryptophan Supplementation Protects Adult Rat Offspring against Hypertension Programmed by Maternal Chronic Kidney Disease: Implication of Tryptophan-Metabolizing Microbiome and Aryl Hydrocarbon Receptor.

Authors:  Chien-Ning Hsu; I-Chun Lin; Hong-Ren Yu; Li-Tung Huang; Mao-Meng Tiao; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2020-06-26       Impact factor: 5.923

3.  Confidence in Women's Health: A Cross Border Survey of Adult Nephrologists.

Authors:  Elizabeth M Hendren; Monica L Reynolds; Laura H Mariani; Jarcy Zee; Michelle M O'Shaughnessy; Andrea L Oliverio; Nicholas W Moore; Peg Hill-Callahan; Dana V Rizk; Salem Almanni; Katherine E Twombley; Emily Herreshoff; Carla M Nester; Michelle A Hladunewich
Journal:  J Clin Med       Date:  2019-02-03       Impact factor: 4.241

4.  Perinatal Resveratrol Therapy Prevents Hypertension Programmed by Maternal Chronic Kidney Disease in Adult Male Offspring: Implications of the Gut Microbiome and Their Metabolites.

Authors:  Chien-Ning Hsu; Chih-Yao Hou; Guo-Ping Chang-Chien; Sufan Lin; Hung-Wei Yang; You-Lin Tain
Journal:  Biomedicines       Date:  2020-12-04

5.  Associations between female birth sex and risk of chronic kidney disease development among people with HIV in the USA: A longitudinal, multicentre, cohort study.

Authors:  Brittany A Shelton; Deirdre Sawinski; Paul A MacLennan; Wonjun Lee; Christina Wyatt; Girish Nadkarni; Huma Fatima; Shikha Mehta; Heidi M Crane; Paige Porrett; Bruce Julian; Richard D Moore; Katerina Christopoulos; Jeffrey M Jacobson; Elmi Muller; Joseph J Eron; Michael Saag; Inga Peter; Jayme E Locke
Journal:  EClinicalMedicine       Date:  2022-09-17

Review 6.  Animal Models for DOHaD Research: Focus on Hypertension of Developmental Origins.

Authors:  Chien-Ning Hsu; You-Lin Tain
Journal:  Biomedicines       Date:  2021-05-31

7.  Maternal Adenine-Induced Chronic Kidney Disease Programs Hypertension in Adult Male Rat Offspring: Implications of Nitric Oxide and Gut Microbiome Derived Metabolites.

Authors:  Chien-Ning Hsu; Hung-Wei Yang; Chih-Yao Hou; Guo-Ping Chang-Chien; Sufan Lin; You-Lin Tain
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.